John Kerr posted in LCT • Living Cell Technologies • neurology • NTCELL • Parkinson's disease • xenotransplantation on June 18th, 2015.
New Zealand company Living Cell Technologies (LCT) have released the results of a small trial of a new Parkinson’s Disease treatment, indicating that their procedure is safe and may improve symptoms. The company’s NTCELL product is based the around implantation of cells derived from pig brain tissue, which help to support neurological function. The results […]
Continue reading “Parkinson’s treatment trial completed”